Search clinical trials for: Rotigotine patch

Total 2043 results

1
2
3
4
5
6
7
8
9
10
...
40
41
›

UCB BIOSCIENCES GmbH

Completed

Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Repeated Dose Transdermal Rotigotine in Japanese and Caucasian Subjects

Healthy

Germany
I.R.C.C.S. Fondazione Santa Lucia

Completed

Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease (DOPAD)

Alzheimer Disease

Italy
I.R.C.C.S. Fondazione Santa Lucia
Alzheimer's Drug Discovery Foundation

Completed

Dopaminergic Therapy for Frontotemporal Dementia Patients

Mental Disorders | Brain Diseases | Central Nervous System Diseases | Nervous System Diseases | Neurologic Manifestations | Neurobehavioral Manifestations | Neurocognitive Disorders | Neurodegenerative Diseases | TDP-43 Proteinopathies | Proteostasis Deficiencies | Dementia | Language Disorders | Communication... and other conditions

Italy
UCB Pharma

Completed

Named Patient Program With Rotigotine Transdermal System

Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine

United States
Xiros Ltd

Recruiting

Post-Market Clinical Follow-up (PMCF) Study of the Pitch-Patch for the Augmentation or Reinforcement of the Rotator Cuff

Rotator Cuff Tear | Rotator Cuff Injuries | Rotator Cuff Tears | Rotator Cuff Tears of the Shoulder

United Kingdom
UCB Pharma

Completed

Study to Compare Adhesiveness of Two Different Rotigotine Patch Formulations

Parkinson's Disease

Germany, Austria, United Kingdom
Schulthess Klinik

Withdrawn

Comparison of Arthroscopic Supraspinatus Tendon Tear Repair in Patients Over 60 Years With and Without Patch Augmentation.

Rotator Cuff Tears
SocraTec R&D GmbH
Luye Pharma Group Ltd.; SocraMetrics GmbH

Completed

Clinical Trial to Investigate Patch Adhesion of Rotigotine Containing Patches in Patients With Parkinson's Disease

Parkinson Disease

Germany
UCB BIOSCIENCES GmbH
Schwarz BioSciences GmbH; Alfred-Nobel-Str. 10; 40789 Monheim am Rhein

Completed

Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects

Healthy

Germany
UCB Pharma

Completed

Study in Healthy Volunteers to Prove That 2 Rotigotine Patches From Different Manufacturing Processes Deliver Equivalent Drug Amount to the Body.

Healthy

Germany
UCB Pharma

Completed

Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body

Healthy Volunteers

Germany
I.R.C.C.S. Fondazione Santa Lucia

Recruiting

A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease (DOPAD-3)

Alzheimer Disease

Italy
Charite University, Berlin, Germany

Not yet recruiting

Cardiac Arrest Post-Discharge ECG Monitoring (CArPEM)

Arrhythmias, Cardiac | Heart Arrest | Electrocardiography
Asan Medical Center

Recruiting

Atrial Fibrillation Detection Using MEMO Patch in Patients With Stroke of Unknown Cause

Embolic Stroke of Undetermined Source

South Korea
University Hospital, Montpellier

Completed

Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome

Restless Legs Syndrome (RLS)

France
UCB Pharma

Completed

Study in Healthy Volunteers to Prove That Two Rotigotine Patches From Different Manufacturing Sites Deliver Equivalent Drug Amount to the Body

Healthy Volunteers

Germany
Université du Québec a Montréal

Recruiting

Personalized Exercises Program Prescription to Prevent Functional Decline Throughout Older Adults Hospitalization

Aging | Hospitalization

Canada
Johns Hopkins University
National Institute on Aging (NIA)

Terminated

Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment (ANXPD)

Parkinson Disease | Anxiety Disorders

United States
Changi General Hospital
Samsung SDS Asia Pacific Pte Ltd

Completed

Comparison of Holter vs S-Patch for Arrhythmia Detection in Older Falls Patient

Arrythmia | Bradyarrhythmia

Singapore
The Cleveland Clinic
Washington University School of Medicine

Recruiting

Surveillance Trial of the Apple Watch in Reliable Burden Assessment in Unseen Recurrence of Surgically Treated AF (STARBURST-AF)

Atrial Fibrillation

United States
East Carolina University

Unknown

Study to Assess Dopamine Receptor Modulation With Rotigotine to Enhance Morphine Analgesia in the Dental Model

Post-op Pain

United States
University of Florida
Food and Drug Administration (FDA)

Completed

Clinical Study to Evaluate the Role of Microdialysis for the Comparison of Topical Products

Bioequivalence

United States
Population Health Research Institute
Canadian Institutes of Health Research (CIHR); University of Leipzig; Heart and... and other collaborators

Completed

Home-Based Screening for Early Detection of Atrial Fibrillation in Primary Care Patients Aged 75 Years and Older (SCREEN-AF)

Hypertension | Atrial Fibrillation

Canada, Germany
Spital Thurgau AG

Recruiting

Patch Study (Patch-augmented Rotator Cuff Repair)

Rotator Cuff Tears

Switzerland
Luye Pharma Group Ltd.

Completed

A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of Rotigotine After a Single Dose of LY03003 (28 mg) Versus After a Week of Daily NEUPRO® Transdermal Patch (4 mg Every 24 Hours) in Healthy Volunteers

Parkinson Disease

United States
Chulalongkorn University
Abbott

Unknown

Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quantitative Assessment by Wearable Sensors

Nocturnal Hypokinesia
UCB Pharma

Completed

Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease Patients

IDIOPATHIC PARKINSON'S DISEASE

China
UCB Pharma
Otsuka Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese Subjects

Healthy Volunteers

Germany
UCB Pharma

Completed

Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine Transdermal Patch in Healthy Chinese Subjects

Healthy

China
UCB Biopharma SRL

Terminated

A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome

Restless Legs Syndrome

United States
Luye Pharma Group Ltd.

Completed

A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro

Parkinson Disease

United States
UCB Pharma SA

Completed

Single-site, Open-label, Randomized, Cross-over Study in Healthy Chinese Subjects to Evaluate the Bioequivalence of Single-dose Rotigotine Transdermal Patch Comparing 2 Different Formulations

Healthy

China
UCB Pharma
UCB Trading (Shanghai) Co. Ltd.

Completed

Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients

Idiopathic Parkinson's Disease

China
Coloplast A/S

Completed

An Exploratory Study Investigating Human Skin Reaction to Output

Ileostomy

Denmark
UCB BIOSCIENCES GmbH
Pharmaceutical Health Sciences; Bracket Global

Completed

A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's Disease

Parkinson's Disease

Germany
Coloplast A/S

Completed

An Exploratory Study Investigating Adhesive Reaction to Output

Ileostomy

Denmark
Otsuka Pharmaceutical Co., Ltd.

Completed

A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome (RLS)

Idiopathic Restless Legs Syndrome
Otsuka Pharmaceutical Co., Ltd.

Completed

A Dose-ranging Study for SPM 962 in Parkinson's Disease Patients

Parkinson's Disease

Japan
En Chu Kong Hospital

Completed

Herbal Patch for Overactive Bladder

Overactive Bladder Syndrome

Taiwan
Serina Therapeutics

Active, not recruiting

A Study of Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214

Parkinson's Disease

United States
GE Healthcare

Completed

Evaluation of the Goldcrest Patch Performance

Fetal Monitoring

United States
McNeil AB

Completed

Cumulative Skin Irritation Potential of a New 25 mg Nicotine Patch

Smoking Cessation

Germany
Sandoz

Terminated

An Open, Randomised, Single Dose, 2-period, 2-sequence Crossover Adhesion Study of Two Different Transdermal Patches Containing Rotigotine.

Parkinson Disease

Germany
Luye Pharma Group Ltd.

Completed

Pharmacokinetic Study of LY03003 in Patients With Parkinson's Disease

Parkinson Disease

United States
Verily Life Sciences LLC

Active, not recruiting

Verily Clinical Study Watch Analytical Validation Study

Chronic Disease | Healthy Population

United States
University of Zurich

Completed

Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects With Epicutanoeus Allergen Administration (ZU-SkinSIT-003)

Allergic Rhinoconjunctivitis

Switzerland
UCB Biopharma SRL

Terminated

A Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome of Unknown Cause

Restless Legs Syndrome

United States
Otsuka Pharmaceutical Co., Ltd.

Completed

A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients

Idiopathic Restless Legs Syndrome

Japan
Baylor College of Medicine

Recruiting

New Pediatric Patching Method to Improve Compliance

Strabismus | Amblyopia

United States
Luye Pharma Group Ltd.

Completed

Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease

Parkinson's Disease

United States

1
2
3
4
5
6
7
8
9
10
...
40
41
›

Subscribe